{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T12:36:58Z","timestamp":1781786218966,"version":"3.54.5"},"reference-count":5,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T00:00:00Z","timestamp":1713052800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust J Dermatology"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Dyshidrotic palmoplantar eczema or pompholyx is considered to be a part of the spectrum of atopic dermatitis with a significant impact on the quality of life and limited treatment options. Tralokinumab is a new fully human monoclonal antibody which neutralizes interleukin 13, a chief cytokine in itch pathogenesis and skin barrier defects. Tralokinumab is FDA\u2010approved for the treatment of atopic dermatitis in adults and EMA\u2010approved for the treatment of atopic dermatitis in adults and adolescents. We, hereby, report a 40\u2010year\u2010old female with severe dyshidrotic palmoplantar eczema who was successfully treated with tralokinumab. To the best of our knowledge, this is the first report of the efficacious use of tralokinumab in dyshidrotic eczema.<\/jats:p>","DOI":"10.1111\/ajd.14268","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T05:24:26Z","timestamp":1713158666000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Successful treatment of dyshidrotic palmoplantar eczema with tralokinumab"],"prefix":"10.1111","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9732-9993","authenticated-orcid":false,"given":"Nisha V.","family":"Parmar","sequence":"first","affiliation":[{"name":"Department of Dermatology DermaMed Clinic  Dubai UAE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar Al","family":"Hammadi","sequence":"additional","affiliation":[{"name":"Department of Dermatology DermaMed Clinic  Dubai UAE"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,4,14]]},"reference":[{"key":"e_1_2_2_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.12.053"},{"issue":"3","key":"e_1_2_2_3_1","first-page":"355","article-title":"Dupilumab in the treatment of dyshidrosis: a report of two cases","volume":"17","author":"Weston GK","year":"2018","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"e_1_2_2_4_1","first-page":"211","article-title":"A case of complete resolution of severe plantar dyshidrotic eczema with dupilumab","volume":"18","author":"Nanda S","year":"2019","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"e_1_2_2_5_1","first-page":"e644","article-title":"Tralokinumab in the treatment of resistant atopic dermatitis: an open\u2010label, retrospective case series study","volume":"37","author":"Pezollo E","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"e_1_2_2_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/ced\/llad038"}],"container-title":["Australasian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajd.14268","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T12:06:52Z","timestamp":1731845212000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ajd.14268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,14]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.1111\/ajd.14268"],"URL":"https:\/\/doi.org\/10.1111\/ajd.14268","archive":["Portico"],"relation":{},"ISSN":["0004-8380","1440-0960"],"issn-type":[{"value":"0004-8380","type":"print"},{"value":"1440-0960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,14]]},"assertion":[{"value":"2023-12-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}